Overview

Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
0
Participant gender:
All
Summary
A Multi-Centered Randomized, Double-Blind, Placebo-Controlled, Phase 2, Exploratory Study to Evaluate the Effect of Rufinamide on Anxiety in Patients with Moderate to Severe Generalized Anxiety Disorder.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Biotie Therapies Inc.
Collaborators:
INC Research
Syneos Health
Treatments:
Rufinamide
Criteria
Inclusion Criteria:

- Outpatient 18-65

- Meet Diagnostic and Statistical Manual,(DSM) IV criteria for GAD

- Have moderate to severe anxiety

- Sign IRB (Institutional Review Board) approved consent and can comply with visits and
procedures

- Women of childbearing potential must use acceptable method of contraception

Exclusion Criteria:

- Have diagnosis of adjustment disorder or anxiety disorder Not otherwise specified
(NOS)

- Have diagnosis of specific phobia

- Have diagnosis of antisocial personality disorder or other Axis II Disorder

- Have diagnosis of substance abuse disorder within 3 months of study entry

- Have diagnosis of major depressive disorder or panic disorder within 6 months of study
entry

- Have diagnosis of PTSD, eating disorder substance dependence disorder within 12 months
of study entry

- Have diagnosis anytime during lifetime of schizophrenia or other psychotic disorder,
bipolar mood disorder, Obsessive-Compulsive Disorder (OCD), psychosurgery

- Require medication to treat GAD other than study medication

- Failed to show improvement with past treatment for GAD

- Excessively consume caffeine

- Are receiving treatment with prohibited medications

- Uncontrolled thyroid condition

- Positive urine drug screen

- Obese

- Clinically significant ECG finding

- Participating in other clinical trial

- Clinically significant out of range lab value

- Past exposure to rufinamide

- Pregnant or nursing females